These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15806597)

  • 1. Standard criteria for relapse are needed in obsessive-compulsive disorder.
    Simpson HB; Franklin ME; Cheng J; Foa EB; Liebowitz MR
    Depress Anxiety; 2005; 21(1):1-8. PubMed ID: 15806597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response versus remission in obsessive-compulsive disorder.
    Simpson HB; Huppert JD; Petkova E; Foa EB; Liebowitz MR
    J Clin Psychiatry; 2006 Feb; 67(2):269-76. PubMed ID: 16566623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder.
    Simpson HB; Liebowitz MR; Foa EB; Kozak MJ; Schmidt AB; Rowan V; Petkova E; Kjernisted K; Huppert JD; Franklin ME; Davies SO; Campeas R
    Depress Anxiety; 2004; 19(4):225-33. PubMed ID: 15274171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research.
    Simpson HB; Petkova E; Cheng J; Huppert J; Foa E; Liebowitz MR
    J Psychiatr Res; 2008 Jul; 42(8):631-8. PubMed ID: 17892885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of obsessive-compulsive disorder.
    Klein DF
    Encephale; 1990; 16 Spec No():331-4. PubMed ID: 2209491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.
    Figueroa Y; Rosenberg DR; Birmaher B; Keshavan MS
    J Child Adolesc Psychopharmacol; 1998; 8(1):61-7. PubMed ID: 9639080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder.
    Hembree EA; Riggs DS; Kozak MJ; Franklin ME; Foa EB
    CNS Spectr; 2003 May; 8(5):363-71, 381. PubMed ID: 12766692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J; Katz R; Landau P; Goodman W; Rasmussen S
    Psychopharmacol Bull; 1990; 26(1):54-9. PubMed ID: 2196627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder.
    Koran LM; Pallanti S; Paiva RS; Quercioli L
    Eur Neuropsychopharmacol; 1998 May; 8(2):121-6. PubMed ID: 9619690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological treatments in obsessive-compulsive disorder].
    Montgomery SA; Fineberg NA; Montgomery D
    Encephale; 1990; 16 Spec No():335-9. PubMed ID: 2209492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating the anxiety: therapeutic options in obsessive compulsive disorder.
    Greist JH
    J Clin Psychiatry; 1990 Nov; 51 Suppl():29-34. PubMed ID: 2146255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obsessive-compulsive disorder and depression].
    López-Ibor Aliño JJ; Saiz Ruiz J; López-Ibor Alcocer MI; Viñas Pifarre R
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(3):97-113. PubMed ID: 7544059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clomipramine and obsessive-compulsive disorder.
    Scahill L; Lynch KA
    J Child Adolesc Psychiatr Nurs; 1995; 8(2):42-5. PubMed ID: 7795952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment.
    McCracken JT; Hanna GL
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):581-7. PubMed ID: 16190790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment.
    Kawahara T; Ueda Y; Mitsuyama Y
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of childhood obsessive-compulsive disorder.
    Leonard HL; Rapoport JL
    Psychiatr Clin North Am; 1989 Dec; 12(4):963-70. PubMed ID: 2690035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features associated with treatment response in obsessive-compulsive disorder.
    Shavitt RG; Belotto C; Curi M; Hounie AG; Rosário-Campos MC; Diniz JB; Ferrão YA; Pato MT; Miguel EC
    Compr Psychiatry; 2006; 47(4):276-81. PubMed ID: 16769302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
    O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P
    J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated approach to treatment of obsessive compulsive disorder.
    Greist JH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.